In partnership with the American Peptide Association

Liquid chromatography system stacked on a laboratory bench beside its control workstation

Analytical testing for research peptides, to pharmaceutical standards.

Identity, purity, strength and safety testing using USP and ICH methods, reported in a certificate of analysis that can be independently verified.

Three programs, one standard

Each program answers a different question, from a core check on every batch to the evidence needed for an American Peptide Association designation. Every program includes a QuantVera certificate of analysis.

Compare programs test by test

Essential Release

Core checks for safety and quality

The six checks every vial should pass. A focused answer to two questions: is it what the label says, and is it clean?

tests
6
frequency
Every batch
per lot
2 vials
  • Sterility
  • Bacterial endotoxins
  • Identity (intact mass)
  • Purity and related substances
  • Net peptide content
  • Structural and conformational screen

Safety 2 · Holistic peptide quality 4

Required to apply for APA designation

Comprehensive Release

The full every-batch release standard

All six Essential Release tests plus 13 more across safety, peptide quality, and manufacturing control, including the vial's physical and delivery attributes.

tests
19
frequency
Every batch
per lot
3 vials
  • Everything in Essential Release
  • Visible particulates, residual solvents, elemental impurities
  • Counterion identity and content
  • Cake appearance, color, clarity, reconstitution time
  • pH, osmolality, fill weight, extractable volume, water content

Safety 5 · Holistic peptide quality 5 · Manufacturing discipline and control 9

Required for full APA designation

Performance Study

Product qualification over its labeled life

Studies that qualify the product, container, and shelf life. Performed per product, formulation, or package, then repeated periodically or after changes.

studies
11
then periodic
Per product
vials
Per plan
  • Functional potency and binding affinity
  • Full sequence confirmation and stereochemistry
  • Aggregation and forced degradation
  • Stability program and container closure integrity
  • Extractables and leachables, headspace oxygen, nitrosamine risk

Safety 1 · Holistic peptide quality 5 · Manufacturing discipline and control 5

Sample racks loaded into an analytical instrument

Methods referenced to USP chapters and ICH guidelines

Every result on a QuantVera certificate names the method that produced it, so the work can be reviewed and repeated.

  • USP <71>Sterility
  • USP <85>Bacterial endotoxins
  • USP <790>Visible particulates
  • USP <467>Residual solvents
  • USP <232> and <233>, ICH Q3DElemental impurities and catalyst residues
  • ICH M7, USP <1469>Mutagenic and nitrosamine risk
  • ICH Q3 reporting thresholdsPurity and related substances
  • USP <631>Color
  • Ph. Eur. 2.2.1Clarity and degree of opalescence
  • USP <791>pH
  • USP <785>Osmolality
  • USP <697>Extractable volume
  • USP <921>Water content
  • ICH Q1A, Q1BDegradation pathways and forced degradation
  • ICH Q1AStability program
  • USP <1207>Container closure integrity
  • USP <1663> and <1664>Extractables and leachables

Submitting samples

Submission is online. The shipping packet is generated when the order is placed.

Submission guide
  1. Online submission

    Enter each product and lot, select a program and review the itemised invoice.

  2. Sample shipment

    Ship sealed vials with the generated packet, which assigns a sample ID to every lot.

  3. Laboratory analysis

    Receipt is confirmed by email and testing begins once every lot has arrived.

  4. Certificate issued

    One certificate per lot, with raw data and a QR code for independent verification.

Certificate of analysis

VQ-EX-0001, Comprehensive Release, issued 29 Sep 2026

This lot meets the Comprehensive Release specification.It is retatrutide, it is 99.1% pure, each vial holds 102% of the labelled 10 mg, and it is sterile.
Sold asGLP-3 10 mg
Identified asRetatrutide
Supplier
Example Supplier LLC
SKU
EX-GLP3-10
Lot
R2609A
Label claim
10 mg per vial
Safety5 of 5 within limit
Holistic peptide quality5 of 5 within limit
Manufacturing discipline and control9 of 9 within limit

Chromatogram, UV 214 nm

0 min2468101214161820

Retatrutide99.1% of peak area12.6 min

Baseline expanded 25x so the impurities are visible. The main peak runs off scale. Select a marker to read a peak.

A certificate of analysis that can be verified

Each result is reported beside its specification, with the chromatogram, the method references and the chain of custody. A QR code confirms the document exactly as issued.

In partnership with the American Peptide Association

Comprehensive Release is required to apply for an APA quality designation, and a Performance Study is required for full designation. Designations are reviewed and issued separately by the APA.

About the partnership

Analysts working at instruments in a laboratory

Discuss a testing requirement

Scope, sample quantities, turnaround and pricing for your products.